account_id none on file
legal_name Telomir Pharmaceuticals, Inc.
ticker TELO
cik 1971532
domain telomirpharma.com
linkedin_company_url https://www.linkedin.com/company/telomir-pharmaceuticals-inc/?viewAsMember=true
entry_point_account_id none on file
name Telomir Pharmaceuticals Inc.
exchange Nasdaq
sector Health Care
sector index/company/sector/health-care/
calls 0 filings 3 executives 2 family 0
why_nownone on file
callsnone on file
filings
Yanez was appointed Chief Financial Officer, Treasurer, and Secretary on June 18, 2024, and was released from this role effective May 16, 2025.
filing / Jul 28, 2026 / receipt
June 3, 2026, the Board appointed Andriy Mushak to serve as the Company’s fractional Chief Financial Officer, effective June 6,
filing / Jul 28, 2026 / receipt
cost savings for companies. We and some brokers household proxy materials, delivering a single proxy statement to multiple shareholders
filing / Jul 28, 2026 / receipt
executives
| Alan Weichselbaum | Chief Financial Officer | - | receipt |
| Michelle Yanez | Chief Financial Officer | - | receipt |
familynone on file
upcoming
| 2026-11-09 | earnings call | scheduled | ir |
changes
| 2025-05-21 | Chief Financial Officer, appointed | sec_8k |
| 2024-06-24 | Chief Financial Officer, appointed | sec_8k |
mcp_package_hint
slug telomir-pharmaceuticals-inc
listing_url https://steadybase.io/company/data/index.json
mcp_url https://mcp.steadybase.io/mcp
steadybase-$